G92.01Immune effector cell-associated neurotoxicity syndrome, grade 1

G92.01 is the ICD-10-CM diagnosis code for immune effector cell-associated neurotoxicity syndrome, grade 1. It belongs to category G92 (toxic encephalopathy), block G89-G99 (other disorders of the nervous system) and chapter 6 (diseases of the nervous system). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within G92.0 (immune effector cell-associated neurotoxicity syndrome), G92.01 is specifically for immune effector cell-associated neurotoxicity syndrome, grade 1. Related codes cover grade unspecified (G92.00), grade 2 (G92.02), grade 3 (G92.03), grade 4 (G92.04) and grade 5 (G92.05).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 023 (Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis with MCC or Antineoplastic Implant or Epilepsy with Neurostimulator, relative weight 5.7444), DRG 024 (Craniotomy with Major Device Implant or Acute Complex CNS Principal Diagnosis without MCC, relative weight 3.9708), DRG 091 (Other Disorders of Nervous System with MCC, relative weight 1.7046), DRG 092 (Other Disorders of Nervous System with CC, relative weight 1.0239), DRG 093 (Other Disorders of Nervous System without CC/MCC, relative weight 0.7783), DRG 791 (Prematurity with Major Problems, relative weight 4.1075) and 1 more, in MDC 01 (Diseases and Disorders of the Nervous System) and MDC 15 (Newborns and Other Neonates with Conditions Originating in the Perinatal Period), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It is not acceptable as the principal diagnosis for an inpatient stay; it may be reported as a secondary diagnosis.

It was added in FY2022, effective October 1, 2021.